Dr. Arshad Rashid Shaikh, MD

Dr. Shaikh practices at Mercyhealth Hospital-Freeport in Freeport, Illinois, part of Mercyhealth.

Dr. Shaikh's NPI, 1093913220, was assigned on July 10, 2007. Dr. Shaikh holds Illinois license 036-118912.

Dr. Shaikh's primary practice is Mercyhealth Hospital-Freeport, at 1045 West Stephenson Street, Freeport, IL 61032 in Stephenson County. The practice phone is (815) 599-6000.

Dr. Shaikh's primary practice is Mercyhealth Hospital-Freeport in Freeport, Illinois, part of Mercyhealth. Dr. Shaikh is also affiliated with Javon Bea Hospital-Riverside. The medical group on file is Mercyhealth Hospital-Freeport. Dmand AI also links Dr. Shaikh to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Shaikh's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaikh practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shaikh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shaikh is licensed in Illinois.

CMS data shows 808 Medicare services from Dr. Shaikh across 9 procedure codes in 2024, for 277 Medicare patients. Medicare paid $57,024 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Shaikh in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shaikh's median patient age at 74, with 62% women.

In 2024, Dr. Shaikh wrote 1,648 Medicare Part D claims for 242 patients. 89% of them were for generic drugs. CMS names the drug for 1,536 of them, across 28 drugs with 11 or more claims each, at $2,804,692 in total drug cost. In 2023, CMS named 1,432 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Shaikh for performance year 2024, reported as part of a group. Dr. Shaikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shaikh as offering telehealth.

Dmand AI links 1 paper to Dr. Shaikh in 2025.

Dmand AI links Dr. Shaikh to 6 clinical trials, 5 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Carcinoma In Situ and Breast Neoplasms, Male. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 173 general payments to Dr. Shaikh from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Astellas Pharma US Inc paid the most, $576.